Abstract:Dikdik Kurnia, 1 Salsabila Aqila Putri, 1 Sefren Geiner Tumilaar, 1 Achmad Zainuddin, 1 Hendra Dian Adhita Dharsono, 2 Meiny Faudah Amin 3 1 Department of Chemistry, Faculty of Mathematics and Natural Sciences, Universitas Padjadjaran, Sumedang, West Java, Indonesia; 2 Department of Conservative Dentistry, Faculty of Dentistry, Universitas Padjadjaran, Sumedang, West Java, Indonesia; 3 Dental Conservation, Faculty of Dentistry, Trisakti University, Jakarta, Indonesia Correspondence: Dikdik Kurnia, Department of Chemistry, Faculty of Mathematics and Natural Sciences, Universitas Padjadjaran, Sumedang, West Java, 45363, Indonesia, Tel/Fax +62-22-7794391, Email Aim: The SARS-CoV-2 virus is a disease that has mild to severe effects on patients, which can even lead to death. One of the enzymes that act as DNA replication is the main protease, which becomes the main target in the inhibition of the SARS-CoV-2 virus. In finding effective drugs against this virus, Ocimum basilicum is a potential herbal plant because it has been tested to have high phytochemical content and bioactivity. Apigenin-7-glucuronide, dihydrokaempferol-3-glucoside, and aesculetin are polyphenolic compounds found in Ocimum basilicum . Purpose: The purpose of this study was to analyze the mechanism of inhibition of the three polyphenolic compounds in Ocimum basilicum against the main protease and to predict pharmacokinetic activity and the drug-likeness of a compound using the Lipinski Rule of Five. Patients and Methods: The method used is to predict the molecular docking inhibition mechanism using Autodock 4.0 tools and use pkcsm and protox online web server to analyze ADMET and Drug-likeness. Results: The binding affinity for apigenin-7-glucuronide was − 8.77 Kcal/mol, dihydrokaempferol-3-glucoside was − 8.96 Kcal/mol, and aesculetin was − 5.79 Kcal/mol. Then, the inhibition constant values were 375.81 nM, 270.09 nM, and 57.11 μM, respectively. Apigenin-7-glucuronide and dihydrokaempferol-3-glucoside bind to the main protease enzymes on the active sites of CYS145 and HIS41, while aesculetin only binds to the active sites of CYS145. On ADMET analysis, these three compounds met the predicted pharmacokinetic parameters, although there are some specific parameters that must be considered especially for aesculetin compounds. Meanwhile, on drug-likeness analysis, apigenin-7-glucuronide and dihydrokaempferol-3-glucoside compounds have one violation and aesculetin have no violation. Conclusion: Based on the data obtained, Apigenin-7-glucuronide and dihydrokaempferol-3-glucoside are compounds that have more potential to have an antiviral effect on the main protease enzyme than aesculetin. Based on pharmacokinetic parameters and drug-likeness, three compounds can be used as lead compounds for further research. Keywords: Apigenin-7-glucuronide, aesculetin, dihydrokaempferol-3-glucoside, main protease, Ocimum basilicum COVID-19 is a global disease that began at the end of 2019. In January 2022, the World Health Organization confirmed that the cumulative cases of COVID-19 were 323,610,370 with a cumulative death of 5,529,693. 1 SARS-CoV-2 is one of seven types of coronaviruses that cause severe lower respiratory tract dysfunction. 2 This virus will bind to ACE2 as the main receptor and spread through the innate immune response in humans. This is a disease that attacks the respiratory tract, which is a mild disease in about 80% of patients. As for about 20% of patients, it can become a severe disease. In a study of 292 COVID-19 patients in Wuhan, there were elderly patients who had an increased risk of 15.15%. Then, congenital diseases such as hypertension, malignant tumors, chronic obstructive pulmonary disease, coronary heart disease, and chronic kidney disease will also be dangerous. This can lead to death if the patient is elderly and has comorbidities. Fifty-one patients out of 145 cases with comorbidities were reported to have died and 90.2% of them were 60 years old. 3–5 Viruses have structural and non-structural proteins, which are classified according to their function. Structural proteins serve as protection against host enzymes so that DNA is not degraded as in the nuclear capsid. While a non-structural protein, the main protease (Mpro), is a cysteine protease enzyme that functions for replication such as chymotrypsin. 6,7 The main protease (Mpro) is an important enzyme that functions as the replication of the corona virus (CoV). It has been identified that Mpro homologues are absent in humans. 8,9 Therefore, research on Mpro inhibitors is very potential and effecti -Abstract Truncated-

Olive Leaf Extract Downregulates the Protein Expression of Key SARS‐CoV‐2 Entry Enzyme ACE‐2, TMPRSS2, and Furin

In vitro biological evaluation and in silico insights into the antiviral activity of standardized olive leaves extract against SARS-CoV-2

Oroxylin A is a Severe Acute Respiratory Syndrome Coronavirus 2‐spiked Pseudotyped Virus Blocker Obtained from Radix Scutellariae Using Angiotensin‐converting Enzyme II/cell Membrane Chromatography

Anisomeles indica Extracts and Their Constituents Suppress the Protein Expression of ACE2 and TMPRSS2 In Vivo and In Vitro

Antiviral activities of olive oil apigenin and taxifolin against SARS-CoV-2 RNA-dependent RNA polymerase (RdRP): In silico, pharmacokinetic, ADMET, and in-vitro approaches

Effect of Oiliness Extract from Rose Family Plant Fruit Core Against Respiratory Tract Viruses in Vitro and in Vivo

Suppression of angiotensin converting enzyme 2, a host receptor for SARS-CoV-2 infection, using 5-aminolevulinic acid in vitro

Identification of Anti-Severe Acute Respiratory Syndrome-Related Coronavirus 2 (SARS-CoV-2) Oxysterol Derivatives In Vitro

Transcriptional regulation and small compound targeting of ACE2 in lung epithelial cells

Eucalyptus Essential Oil Inhibits Cell Infection by SARS-CoV-2 Spike Pseudotyped Lentivirus

Antimalarial Artefenomel Inhibits Human SARS-CoV-2 Replication in Cells while Suppressing the Receptor ACE2

Antrodia cinnamomea May Interfere with the Interaction Between ACE2 and SARS-CoV-2 Spike Protein in vitro and Reduces Lung Inflammation in a Hamster Model of COVID-19

Oxalic acid blocked the binding of spike protein from SARS-CoV-2 Delta (B.1.617.2) and Omicron (B.1.1.529) variants to human angiotensin-converting enzymes 2

In silico Study of Antiviral Activity of Polyphenol Compounds from Ocimum basilicum by Molecular Docking, ADMET, and Drug-Likeness Analysis

Identification of a pharmacological approach to reduce ACE2 expression and development of an in vitro COVID-19 viral entry model

Promising Antiviral Activity of Agrimonia pilosa Phytochemicals against Severe Acute Respiratory Syndrome Coronavirus 2 Supported with In Vivo Mice Study

Two Resveratrol Oligomers Inhibit Cathepsin L Activity to Suppress SARS-CoV-2 Entry

Eucalyptus Oils Phytochemical Composition in Correlation with Their Newly Explored Anti-SARS-CoV-2 Potential: in Vitro and in Silico Approaches

The exploration of phytocompounds theoretically combats SARS-CoV-2 pandemic against virus entry, viral replication and immune evasion

ACE2 can be a target for therapeutic purpose of COVID-19

Potent prophylactic and therapeutic efficacy of recombinant human ACE2-Fc against SARS-CoV-2 infection in vivo